HAVN Life Sciences Inc. (HAVLF)
Sector: Biotechnology
Industry: Biotechnology
HAVN Life Sciences Inc.
OTC:HAVLFHealthcare · Biotechnology
CLOSED
Mkt Cap$3K
EV-
Float23.1M
O/S25.65M
VOL116 sh
RVOL1.00×
Inst Own-
Net Cash/Sh-
Dilution
MCap$3KFloat23.1MO/S25.65M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 11, 2026 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 116 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About
HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms.
The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.
Key Metrics
Market Cap$2,565
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 25.65M shares outstanding
SectorHealthcare
IndustryBiotechnology
ExchangeOTC
Country
CA
IPO Date-
Shares Outstanding25.65M
Authorized Shares
Float23.10M
52-Week Range
Volume
Average Daily Volume116
30d Avg
116
60d Avg
116
90d Avg
231
Earnings
Dividend History
No dividend history available